Psychedelic Psychiatry's Brave New World - PubMed
- ️Wed Jan 01 2020
. 2020 Apr 2;181(1):24-28.
doi: 10.1016/j.cell.2020.03.020.
Affiliations
- PMID: 32243793
- DOI: 10.1016/j.cell.2020.03.020
Free article
Psychedelic Psychiatry's Brave New World
David Nutt et al. Cell. 2020.
Free article
Abstract
After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results. Outcomes of neuroscience and clinical research into 5-Hydroxytryptamine 2A (5-HT2A) receptor agonists, such as psilocybin, show promise for addressing a range of serious disorders, including depression and addiction.
Copyright © 2020 Elsevier Inc. All rights reserved.
Comment in
-
Commentary: Psychedelic Psychiatry's Brave New World.
Nobile B, Olié E, Courtet P. Nobile B, et al. Front Psychiatry. 2020 Nov 26;11:594077. doi: 10.3389/fpsyt.2020.594077. eCollection 2020. Front Psychiatry. 2020. PMID: 33324259 Free PMC article. No abstract available.
Similar articles
-
The Therapeutic Potential of Psilocybin.
Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L. Lowe H, et al. Molecules. 2021 May 15;26(10):2948. doi: 10.3390/molecules26102948. Molecules. 2021. PMID: 34063505 Free PMC article. Review.
-
Psychedelics as Medicines: An Emerging New Paradigm.
Nichols DE, Johnson MW, Nichols CD. Nichols DE, et al. Clin Pharmacol Ther. 2017 Feb;101(2):209-219. doi: 10.1002/cpt.557. Epub 2016 Dec 26. Clin Pharmacol Ther. 2017. PMID: 28019026 Review.
-
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.
Carhart-Harris RL, Goodwin GM. Carhart-Harris RL, et al. Neuropsychopharmacology. 2017 Oct;42(11):2105-2113. doi: 10.1038/npp.2017.84. Epub 2017 Apr 26. Neuropsychopharmacology. 2017. PMID: 28443617 Free PMC article. Review.
-
Psychedelic drugs-a new era in psychiatry? .
Nutt D. Nutt D. Dialogues Clin Neurosci. 2019;21(2):139-147. doi: 10.31887/DCNS.2019.21.2/dnutt. Dialogues Clin Neurosci. 2019. PMID: 31636488 Free PMC article. Review.
-
Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.
Thomas K, Malcolm B, Lastra D. Thomas K, et al. J Psychoactive Drugs. 2017 Nov-Dec;49(5):446-455. doi: 10.1080/02791072.2017.1320734. Epub 2017 May 8. J Psychoactive Drugs. 2017. PMID: 28481178 Review.
Cited by
-
The promises and perils of psychedelic pharmacology for psychiatry.
McClure-Begley TD, Roth BL. McClure-Begley TD, et al. Nat Rev Drug Discov. 2022 Jun;21(6):463-473. doi: 10.1038/s41573-022-00421-7. Epub 2022 Mar 17. Nat Rev Drug Discov. 2022. PMID: 35301459 Review.
-
Vilca-Melendez S, Uthaug MV, Griffin JL. Vilca-Melendez S, et al. Front Psychiatry. 2021 Dec 13;12:742856. doi: 10.3389/fpsyt.2021.742856. eCollection 2021. Front Psychiatry. 2021. PMID: 34966300 Free PMC article. Review.
-
Barbut Siva J, Barba T, Kettner H, Kuc J, Nutt DJ, Carhart-Harris R, Erritzoe D. Barbut Siva J, et al. J Psychopharmacol. 2024 Feb;38(2):145-155. doi: 10.1177/02698811231224217. Epub 2024 Jan 27. J Psychopharmacol. 2024. PMID: 38281075 Free PMC article.
-
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor.
Kim K, Che T, Panova O, DiBerto JF, Lyu J, Krumm BE, Wacker D, Robertson MJ, Seven AB, Nichols DE, Shoichet BK, Skiniotis G, Roth BL. Kim K, et al. Cell. 2020 Sep 17;182(6):1574-1588.e19. doi: 10.1016/j.cell.2020.08.024. Cell. 2020. PMID: 32946782 Free PMC article.
-
Psilocybin for Depression: From Credibility to Feasibility, What's Missing?
Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G. Munafò A, et al. Pharmaceuticals (Basel). 2022 Dec 31;16(1):68. doi: 10.3390/ph16010068. Pharmaceuticals (Basel). 2022. PMID: 36678564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical